Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
3:23cv1657 • September 8, 2023
Class Period Start
August 3, 2022
Class Period End
November 2, 2022
PSLRA Deadline
November 7, 2023
Case Allegations
10b5
Statutes of Repose
Aug 3, 2025
Country
United States
Court
Federal Court
May 30, 2024
No Appeal- Closed
Apr 30, 2024
Motion to Dismiss Granted
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Mar 11, 2024
Motion to Dismiss
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Feb 1, 2024
First Amended Complaint
A new complaint has been filed on behalf of certain investors in TANDEM DIABETES CARE INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Dec 5, 2023
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
TOP
